These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19690646)

  • 1. Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.
    Eldesoky ES; Kamel SI; Farghaly AM; Bakheet MY; Hedaya MA; Siest JP
    Biomark Insights; 2007 Feb; 1():157-64. PubMed ID: 19690646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of urinary 6 beta-hydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population.
    El Desoky ES; Mohamed HO; Farghaly WM; Hamed SA; Hedaya MA; Siest JP
    Pharmacol Res; 2005 Jun; 51(6):575-80. PubMed ID: 15829439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers.
    Makhova AA; Shikh EV; Bulko TV; Sizova ZM; Shumyantseva VV
    Drug Metab Pers Ther; 2019 Oct; 34(3):. PubMed ID: 31603853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morning spot and 24-hour urinary 6 beta-hydroxycortisol to cortisol ratios: intraindividual variability and correlation under basal conditions and conditions of CYP 3A4 induction.
    Tran JQ; Kovacs SJ; McIntosh TS; Davis HM; Martin DE
    J Clin Pharmacol; 1999 May; 39(5):487-94. PubMed ID: 10234596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity.
    Lutz U; Bittner N; Ufer M; Lutz WK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):97-101. PubMed ID: 19959402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk.
    Zheng W; Jin F; Dunning LA; Shu XO; Dai Q; Wen WQ; Gao YT; Holtzman JL
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):237-42. PubMed ID: 11303593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal variation of 6beta-hydroxycortisol in cardiac patients.
    Micuda S; Sispera L; Hodac M; Parízek P; Fuksa L; Brcáková E; Cerman J; Cermanová J; Martínková J
    Physiol Res; 2007; 56(3):307-313. PubMed ID: 16792464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced urinary 6beta-hydroxycortisol to cortisol ratios in patients with liver cirrhosis.
    Shibuya M; Echizen H; Kubo S; Tamura N; Suzuki K; Ushiama H; Ohnishi A
    Hepatol Res; 2003 May; 26(1):28-33. PubMed ID: 12787801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a monoclonal antibody to 6 beta-hydroxycortisol and its application in an enzyme-linked immunosorbent assay (ELISA) for 6 beta-hydroxycortisol in urine.
    Yeung JH; Wong JK; Park BK
    J Pharmacol Toxicol Methods; 1997 Oct; 38(2):71-9. PubMed ID: 9403777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases.
    Ng MC; Young RP; Critchley JA; Leung NW; Lau JW; Li AK
    Cancer; 1996 Apr; 77(8):1427-33. PubMed ID: 8608525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variability of liver graft function and urinary 6beta-hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipients.
    Kishino S; Ogawa M; Takekuma Y; Sugawara M; Shimamura T; Furukawa H; Todo S; Miyazaki K
    Clin Transplant; 2004 Apr; 18(2):124-9. PubMed ID: 15016124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a screening method for anti-6 beta-hydroxycortisol antibody using an enzyme-linked immunosorbent assay (ELISA) and its applications.
    Yeung JH; Wong JK; Park BK
    Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):79-86. PubMed ID: 9151282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 3A4 activity in premenopausal and postmenopausal women, based on 6-beta-hydroxycortisol:cortisol ratios.
    Burstein AH; Reiss WG; Kantor E; Anderson GD
    Pharmacotherapy; 1998; 18(6):1271-6. PubMed ID: 9855326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.
    Yeo KP; Lowe SL; Lim MT; Voelker JR; Burkey JL; Wise SD
    Br J Clin Pharmacol; 2006 Feb; 61(2):200-10. PubMed ID: 16433874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 6 beta-hydroxycortisol excretion in rheumatoid arthritis.
    Beyeler C; Frey BM; Bird HA
    Br J Rheumatol; 1997 Jan; 36(1):54-8. PubMed ID: 9117175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polychlorinated biphenyl (PCB) induction of CYP3A4 enzyme activity in healthy Faroese adults.
    Petersen MS; Halling J; Damkier P; Nielsen F; Grandjean P; Weihe P; Brøsen K
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):202-6. PubMed ID: 17692354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.
    Ohno M; Yamaguchi I; Ito T; Saiki K; Yamamoto I; Azuma J
    Eur J Clin Pharmacol; 2000; 55(11-12):861-5. PubMed ID: 10805065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of grapefruit juice on cortisol metabolism in healthy male Chinese subjects.
    Xiao YJ; Hu M; Tomlinson B
    Food Chem Toxicol; 2014 Dec; 74():85-90. PubMed ID: 25265455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No impact of vitamin D on the CYP3A biomarker 4β-hydroxycholesterol in patients with abnormal glucose regulation.
    Mannheimer B; Wagner H; Östenson CG; Diczfalusy U
    PLoS One; 2015; 10(4):e0121984. PubMed ID: 25835492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.